Kinvard Bio

Funding and NIH signals

• NIH award NIH awarded $314K (SBIR Phase I 1R43AI197431-01, new, notice Aug 3, 2026). NIH RePORTER 1R43AI197431-01 (Aug 3, 2026)
  Evidence (1 event)

  • Aug 3, 2026 · NIH RePORTER 1R43AI197431-01
    Organization: KINVARD BIO, INC.; City/State: FLOURTOWN, PA; Project number: 1R43AI197431-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-03; FY total cost (award amount): 314363; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Development of oxepanoprolinamide antibiotics for the treatment of complicated urinary tract infections.; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals